(Q37796034)

23 August 2017

Deep brain stimulation state of the art and novel stimulation targets (English)

1 reference

23 August 2017

deep brain stimulation

1 reference

2

Andres M Lozano

1 reference

23 August 2017

Francisco A Ponce

1

1 reference

23 August 2017

1 January 2010

1 reference

Progress in Brain Research

23 August 2017

1 reference

23 August 2017

184

1 reference

23 August 2017

311-324

1 reference

Frequency of bowel movements and the future risk of Parkinson's disease

23 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Beating a dead horse: dopamine and Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Improvement of sleep architecture in PD with subthalamic nucleus stimulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Abnormal sleep and sleepiness in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Long-term cognitive profile and incidence of dementia after STN-DBS in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Targeting the caudal intralaminar nuclei for functional neurosurgery of movement disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Acute and long-term effects of subthalamic nucleus stimulation in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Cognitive dysfunction and dementia in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Amygdala pathology in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Staging of brain pathology related to sporadic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

High frequency stimulation of the subthalamic nucleus increases the extracellular contents of striatal dopamine in normal and partially dopaminergic denervated rats

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Comparison of pallidal and subthalamic nucleus deep brain stimulation for advanced Parkinson's disease: results of a randomized, blinded pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Predictors of effective bilateral subthalamic nucleus stimulation for PD

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Axonal and somatic filtering of antidromically evoked cortical excitation by simulated deep brain stimulation in rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Effects of deep brain stimulation of the subthalamic nucleus on sleep architecture in parkinsonian patients

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Where does parkinson disease pathology begin in the brain?

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Is DBS-STN appropriate to treat severe Parkinson disease in an elderly population?

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

A randomized trial of deep-brain stimulation for Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

The effect of deep brain stimulation on quality of life in movement disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Long-term follow-up of globus pallidus chronic stimulation in advanced Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Effects of pedunculopontine nucleus area stimulation on gait disorders in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Effects of subthalamic nucleus stimulation on urodynamic findings in patients with Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

High-frequency stimulation of the subthalamic nucleus modulates the activity of pedunculopontine neurons through direct activation of excitatory fibres as well as through indirect activation of inhibitory pallidal fibres in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Effect of subthalamic nucleus stimulation on levodopa-induced dyskinesia in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Spinal cord stimulation restores locomotion in animal models of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Biochemical and electrophysiological changes of substantia nigra pars reticulata driven by subthalamic stimulation in patients with Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Oscillations in the basal ganglia under normal conditions and in movement disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Efficiency and safety of bilateral contemporaneous pallidal stimulation (deep brain stimulation) in levodopa-responsive patients with Parkinson's disease with severe motor fluctuations: a 2-year follow-up review

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Stereotactic coordinates associated with facial musculature contraction during high-frequency stimulation of the subthalamic nucleus

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Optical deconstruction of parkinsonian neural circuitry

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

No tissue damage by chronic deep brain stimulation in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Latest view on the mechanism of action of deep brain stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Pathological synchronization in Parkinson's disease: networks, models and treatments

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Anatomical and electrophysiological studies on the reciprocal projections between the subthalamic nucleus and nucleus tegmenti pedunculopontinus in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Depression in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Clinical correlates of selective pathology in the amygdala of patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Bilateral subthalamic nucleus stimulation in a parkinsonian patient with preoperative deficits in speech and cognition: persistent improvement in mobility but increased dependency: a case study

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Multicenter study on deep brain stimulation in Parkinson's disease: an independent assessment of reported adverse events at 4 years.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Stimulation of the subthalamic nucleus changes the firing pattern of pallidal neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Two-year follow-up of subthalamic deep brain stimulation in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Disease progression continues in patients with advanced Parkinson's disease and effective subthalamic nucleus stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Deep brain stimulation of the subthalamic nucleus does not increase the striatal dopamine concentration in parkinsonian humans

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Biochemistry of Parkinson's disease with special reference to the dopaminergic systems.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Neuronal loss in the pedunculopontine tegmental nucleus in Parkinson disease and in progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Improvement of sleep quality in patients with advanced Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Subthalamic DBS replaces levodopa in Parkinson's disease: two-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Quetiapine for insomnia in Parkinson disease: results from an open-label trial

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Dementia and visual hallucinations associated with limbic pathology in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Impact of surgery targeting the caudal intralaminar thalamic nuclei on the pathophysiological functioning of basal ganglia in a rat model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Activation by attention of the human reticular formation and thalamic intralaminar nuclei

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Long-term follow up of bilateral deep brain stimulation of the subthalamic nucleus in patients with advanced Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

High-frequency stimulation of the subthalamic nucleus prolongs the increase in striatal dopamine induced by acute l-3,4-dihydroxyphenylalanine in dopaminergic denervated rats

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Bilateral subthalamic nucleus stimulation improves health-related quality of life in PD.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Deep brain stimulation: preoperative issues

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Clinical and physiological assessments for elucidating falls risk in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Neurotransmitter release from high-frequency stimulation of the subthalamic nucleus

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Improvement in quality of life in patients with advanced Parkinson's disease following bilateral deep-brain stimulation in subthalamic nucleus

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Deep brain stimulation for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Effect of chronic pallidal deep brain stimulation on off period dystonia and sensory symptoms in advanced Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Deep brain stimulation surgery for Parkinson's disease: mechanisms and consequences

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Long-term benefits in quality of life provided by bilateral subthalamic stimulation in patients with Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Subthalamic stimulation and neuronal activity in the substantia nigra in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Nigrostriatal rAAV-mediated GDNF overexpression induces robust weight loss in a rat model of age-related obesity.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Motor complications in Parkinson's disease and the clinical significance of rotational behavior in the rat: have we wasted our time?

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Implantation of human pedunculopontine nucleus: a safe and clinically relevant target in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Cellular effects of deep brain stimulation: model-based analysis of activation and inhibition.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

High‐frequency stimulation of the subthalamic nucleus enhances striatal dopamine release and metabolism in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Comparison of ligament-balancing techniques during total knee arthroplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Neurochemical modulation of the P13 midlatency auditory evoked potential in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Effects of stimulation of the centromedian nucleus of the thalamus on the activity of striatal cells in awake rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

The pedunculopontine nucleus in Parkinson's disease: primate studies

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Deep brain stimulation of the pedunculopontine region in the normal non-human primate.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Evolution of Parkinson's disease during 4 years of bilateral deep brain stimulation of the subthalamic nucleus.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Effects of bilateral stimulation of the subthalamic nucleus in patients with severe Parkinson's disease and motor fluctuations.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

The pedunculopontine nucleus and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

The neuropathologic basis of different clinical subgroups of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Deep brain stimulation of the pedunculopontine nucleus in Parkinson's disease. Preliminary experience at Oxford

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Changes induced by levodopa and subthalamic nucleus stimulation on parkinsonian speech

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Bilateral deep brain stimulation of the pedunculopontine nucleus for Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Subthalamic nucleus-mediated excitotoxicity in Parkinson's disease: a target for neuroprotection.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Efficacy of deep brain stimulation of the subthalamic nucleus in Parkinson's disease 4 years after surgery: double blind and open label evaluation.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

What contributes to quality of life in patients with Parkinson's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Stimulation of the subthalamic nucleus in Parkinson's disease: a 5 year follow up

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Effect of subthalamic deep brain stimulation on the function of the urinary bladder.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Multi-target strategy for Parkinsonian patients: the role of deep brain stimulation in the centromedian-parafascicularis complex.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Subthalamic deep brain stimulation does not induce striatal dopamine release in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Protection of nigral cell death by bilateral subthalamic nucleus stimulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

The regulation of adult rodent hippocampal neurogenesis by deep brain stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Neural synchrony in brain disorders: relevance for cognitive dysfunctions and pathophysiology

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Long-term effects of pallidal or subthalamic deep brain stimulation on quality of life in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Bilateral high-frequency stimulation of the internal globus pallidus in advanced Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Deep brain stimulation: neuropsychological and neuropsychiatric issues

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Neuropathology of autonomic nervous system in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Survival of midbrain dopaminergic cells after lesion or deep brain stimulation of the subthalamic nucleus in MPTP-treated monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Center median-parafascicular complex and pain control. Review from a neurosurgical perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Pedunculopontine nucleus microelectrode recordings in movement disorder patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Clinical predictive factors of subthalamic stimulation in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Control of locomotion in the decerebrate cat.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Lower urinary tract symptoms and bladder control in advanced Parkinson's disease: effects of deep brain stimulation in the subthalamic nucleus.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Effect of bilateral subthalamic nucleus stimulation on parkinsonian gait

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

Motor and nonmotor symptom follow-up in parkinsonian patients after deep brain stimulation of the subthalamic nucleus.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

From off-period dystonia to peak-dose chorea. The clinical spectrum of varying subthalamic nucleus activity

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984016-6

7 January 2021

10.1016/S0079-6123(10)84016-6

Identifiers

DOI

1 reference

23 August 2017

1 reference

PubMed ID

20887882